These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2663447)

  • 1. [Dopaminergic agonists and mood disorders].
    Zann M; Colonna L
    Encephale; 1989; 15 Spec No():201-7. PubMed ID: 2663447
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of dopamine in mood disorders.
    Diehl DJ; Gershon S
    Compr Psychiatry; 1992; 33(2):115-20. PubMed ID: 1347497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlations between the EEG pattern of sleep and depressive syndrome in patients with bipolar affective disorders before and during treatment with amitriptyline].
    Ekiert H; Gogol Z; Jernajczyk W
    Psychiatr Pol; 1983; 17(4):287-93. PubMed ID: 6657811
    [No Abstract]   [Full Text] [Related]  

  • 4. [The relevance of dopamine agonists in the treatment of depression].
    Clausius N; Born C; Grunze H
    Neuropsychiatr; 2009; 23(1):15-25. PubMed ID: 19272288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin in mood disorders.
    Srinivasan V; Smits M; Spence W; Lowe AD; Kayumov L; Pandi-Perumal SR; Parry B; Cardinali DP
    World J Biol Psychiatry; 2006; 7(3):138-51. PubMed ID: 16861139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of dopamine in mood disorders.
    Fochtmann L; Fink M
    Compr Psychiatry; 1992; 33(6):417-8. PubMed ID: 1298235
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder.
    Berk M; Dodd S; Kauer-Sant'anna M; Malhi GS; Bourin M; Kapczinski F; Norman T
    Acta Psychiatr Scand Suppl; 2007; (434):41-9. PubMed ID: 17688462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrinology of mood disorders.
    Mazza M; Satta MA; Bria P; Mazza S
    Clin Ter; 2004; 155(11-12):537-41. PubMed ID: 15861968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of endothelial function in unipolar and bipolar depression.
    Rybakowski JK; Wykretowicz A; Heymann-Szlachcinska A; Wysocki H
    Biol Psychiatry; 2006 Oct; 60(8):889-91. PubMed ID: 16730331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in the interhemispheric interaction in patients with an affective pathology and schizophrenia].
    Egorov AIu; Ivanov OV; Nikolaenko NN
    Fiziol Cheloveka; 1999; 25(3):34-40. PubMed ID: 10822622
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dysthymic disorders and dopaminergic drugs].
    Schmitt L; Olivier F; Fournié-DeJean I
    Encephale; 1992 Dec; 18 Spec No 5():755-9. PubMed ID: 1364157
    [No Abstract]   [Full Text] [Related]  

  • 12. Bromocriptine augmentation therapy in a patient with Cotard's syndrome.
    Kondo S; Hayashi H; Eguchi T; Oyama T; Wada T; Otani K
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):719-21. PubMed ID: 12787862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug treatment of bipolar depression and mania.
    Cookson JC
    Br J Hosp Med; 1985 Sep; 34(3):172-5. PubMed ID: 2865999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selected parameters of sleep as a predictive factor in the selection of an antidepressant].
    Nowicki Z
    Psychiatr Pol; 1988; 22(5):330-5. PubMed ID: 3072581
    [No Abstract]   [Full Text] [Related]  

  • 15. Abnormal anterior pituitary responsiveness to hypothalamic hormones in depression: neurophysiological correlates and psychopharmacological effects.
    Brambilla F; Pugnetti L; Scarone S; Gambini O; Maggioni M; Nobile P
    Adv Biochem Psychopharmacol; 1985; 40():69-80. PubMed ID: 3927662
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine agonist amineptine prevents the antidepressant effect of sleep deprivation.
    Benedetti F; Barbini B; Campori E; Colombo C; Smeraldi E
    Psychiatry Res; 1996 Dec; 65(3):179-84. PubMed ID: 9029666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "On-off" phenomena and manic-depressive mood shifts: case report.
    Keshavan MS; David AS; Narayanen HS; Satish P
    J Clin Psychiatry; 1986 Feb; 47(2):93-4. PubMed ID: 3944072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of fatty acids in the development and treatment of mood disorders.
    Owen C; Rees AM; Parker G
    Curr Opin Psychiatry; 2008 Jan; 21(1):19-24. PubMed ID: 18281836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and neuroendocrine effects of opioid receptor agonists in psychopathologic states.
    Judd LL; Risch SC; Segal DS; Janowsky DS; Huey LY
    Psychiatr Clin North Am; 1983 Sep; 6(3):393-402. PubMed ID: 6359090
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects and management of the menopausal transition in women with depression and bipolar disorder.
    Soares CN; Taylor V
    J Clin Psychiatry; 2007; 68 Suppl 9():16-21. PubMed ID: 17764380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.